HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
ABT 255
structure in first source
Also Known As:
ABT-255
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
1-Ring Heterocyclic Compounds
Pyridines: 88
Pyridones: 14
ABT 255: 1
Related Diseases
1.
Pulmonary Tuberculosis
10/01/1998 - "
tuberculosis isolates was 0.031 microg/ml. In a murine model of pulmonary tuberculosis, 4 weeks of oral ABT-255 therapy produced a 2- to 5-log10 reduction in viable drug-susceptible M.
"
2.
Tuberculosis (Tuberculoses)
10/01/1998 - "
tuberculosis, ABT-255 produced a 2- to 3-log10 reduction in viable bacterial counts from lung tissue.
"
10/01/1998 - "
tuberculosis isolates was 0.031 microg/ml. In a murine model of pulmonary tuberculosis, 4 weeks of oral ABT-255 therapy produced a 2- to 5-log10 reduction in viable drug-susceptible M.
"
10/01/1998 - "
tuberculosis ranged from 0.016 to 0.031 microg/ml. The MIC of ABT-255 against rifampin- or ethambutol-resistant M.
"
Related Drugs and Biologics
1.
Rifampin (Rifampicin)
2.
Ethambutol (Myambutol)
Related Therapies and Procedures
1.
Therapeutics